Unibest 优贝德
← 返回专利悬崖列表

阿托吉泮

Tier C · 观察 / 贸易

Atogepant

Merck & Co Inc
原研
2021
首批上市
-
到期年(公开口径)
无销量数据
峰值销售
化学药
类型

靶点:CGRPR

商品名:Aquipta、QULIPTA、Qulipta

适应症(已批准):偏头痛

各地区研发/上市状态

美国
批准上市
2021-09-28
欧盟
批准上市
2023-08-11
中国
申请上市
2026-01-08
日本
批准上市
2026-02-19

合成路线与中间体7 routes

原研路线 × 2优化路线(非专利)× 5工艺路线 × 0

路线按「原研路线 → 优化路线 / 工艺路线(非专利)」排序。每条路线附本站自绘的路线流程图(中间体 → 原料药)与中间体表(编号 / CAS / 英文名),可直接用于供应商开发与询价。流程图由本站依据已授权的结构化数据自行渲染,未使用任何第三方路线图。

原研Route 1步骤 8 · 总收率 5.4 g
MK-8031-001114152-23-7MK-8031-002—MK-8031-0031305324-34-8MK-8031-0041456803-29-4MK-8031-005—MK-8031-0061456803-42-1MK-8031-007—MK-8031-0086226-25-1MK-8031-0091375471-12-7MK-8031-0101375794-72-1MK-8031-0111375541-21-1API · 阿托吉泮
编号CAS 号中间体名称
MK-8031-001114152-23-7在售2-(2,3,6-trifluorophenyl)acetic acid
MK-8031-002-N-methoxy-N-methyl-2-(2,3,6-trifluorophenyl)acetamide
MK-8031-0031305324-34-8在售1-(2,3,6-trifluorophenyl)propan-2-one
MK-8031-0041456803-29-4在售isopropyl N-(tert-butoxycarbonyl)-O-(methylsulfonyl)serinate
MK-8031-005-tert-butyl 2-((tert-butoxycarbonyl)amino)-5-oxo-4-(2,3,6-trifluorophenyl)hexanoate
MK-8031-0061456803-42-1在售tert-butyl ((5S,6R)-6-methyl-2-oxo-5-(2,3,6-trifluorophenyl)piperidin-3-yl)carbamate
MK-8031-007-tert-butyl ((3S,5S,6R)-6-methyl-2-oxo-5-(2,3,6-trifluorophenyl)piperidin-3-yl)carbamate
MK-8031-0086226-25-1在售2,2,2-trifluoroethyl trifluoromethanesulfonate
MK-8031-0091375471-12-7在售tert-butyl ((5S,6R)-6-methyl-2-oxo-1-(2,2,2-trifluoroethyl)-5-(2,3,6-trifluorophenyl)piperidin-3-yl)carbamate
MK-8031-0101375794-72-1在售(3S,5S,6R)-6-methyl-2-oxo-1-(2,2,2-trifluoroethyl)-5-(2,3,6-trifluorophenyl)piperidin-3-aminium acetyl-L-phenylalaninate
MK-8031-0111375541-21-1在售(S)-2'-oxo-1',2',5,7-tetrahydrospiro[cyclopenta[b]pyridine-6,3'-pyrrolo[2,3-b]pyridine]-3-carboxylic acid
原研Route 7步骤 3 · 总收率 5.40 g
MK-8031-055367-23-7MK-8031-0561456803-49-8MK-8031-0571456803-50-1API · 阿托吉泮
编号CAS 号中间体名称
MK-8031-055367-23-7在售1,2,4-trifluorobenzene
MK-8031-0561456803-49-8在售3-hydroxy-3-(2,3,6-trifluorophenyl)butan-2-one
MK-8031-0571456803-50-1在售3-(2,3,6-trifluorophenyl)but-3-en-2-one
优化Route 2步骤 8 · 总收率 /
MK-8031-01254923-31-8MK-8031-0136226-25-1MK-8031-0141375471-02-5MK-8031-015247564-71-2MK-8031-016—MK-8031-017—MK-8031-0181375471-11-6MK-8031-0191375471-12-7API · 阿托吉泮
编号CAS 号中间体名称
MK-8031-01254923-31-8在售5-bromo-6-methylpyridin-2(1H)-one
MK-8031-0136226-25-1在售2,2,2-trifluoroethyl trifluoromethanesulfonate
MK-8031-0141375471-02-5在售5-bromo-6-methyl-1-(2,2,2-trifluoroethyl)pyridin-2(1H)-one
MK-8031-015247564-71-2在售(2,3,6-trifluorophenyl)boronic acid
MK-8031-016-6-methyl-1-(2,2,2-trifluoroethyl)-5-(2,3,6-trifluorophenyl)pyridin-2(1H)-one
MK-8031-017-(5S,6R)-6-methyl-1-(2,2,2-trifluoroethyl)-5-(2,3,6-trifluorophenyl)piperidin-2-one
MK-8031-0181375471-11-6在售(5S,6R)-3-azido-6-methyl-1-(2,2,2-trifluoroethyl)-5-(2,3,6-trifluorophenyl)piperidin-2-one
MK-8031-0191375471-12-7在售tert-butyl ((5S,6R)-6-methyl-2-oxo-1-(2,2,2-trifluoroethyl)-5-(2,3,6-trifluorophenyl)piperidin-3-yl)carbamate
优化Route 3步骤 11 · 总收率 /
MK-8031-020271-63-6MK-8031-021879132-46-4MK-8031-022879132-47-5MK-8031-023879132-48-6MK-8031-02452011-50-4MK-8031-025957122-45-1MK-8031-02614150-94-8MK-8031-027957122-46-2MK-8031-028957122-47-3MK-8031-029957122-44-0MK-8031-0301059186-43-4MK-8031-0311189570-15-7MK-8031-0321375541-24-4API · 阿托吉泮
编号CAS 号中间体名称
MK-8031-020271-63-6在售1H-pyrrolo[2,3-b]pyridine
MK-8031-021879132-46-4在售1-((2-(trimethylsilyl)ethoxy)methyl)-1H-pyrrolo[2,3-b]pyridine
MK-8031-022879132-47-5在售3,3-dibromo-1-((2-(trimethylsilyl)ethoxy)methyl)-1,3-dihydro-2H-pyrrolo[2,3-b]pyridin-2-one
MK-8031-023879132-48-6在售1-((2-(trimethylsilyl)ethoxy)methyl)-1,3-dihydro-2H-pyrrolo[2,3-b]pyridin-2-one
MK-8031-02452011-50-4在售1,4-dibromobutan-2-one
MK-8031-025957122-45-1在售1'-((2-(trimethylsilyl)ethoxy)methyl)spiro[cyclopentane-1,3'-pyrrolo[2,3-b]pyridine]-2',3(1'H)-dione
MK-8031-02614150-94-8在售1-methyl-3,5-dinitropyridin-2(1H)-one
MK-8031-027957122-46-2在售3-nitro-1'-((2-(trimethylsilyl)ethoxy)methyl)-5,7-dihydrospiro[cyclopenta[b]pyridine-6,3'-pyrrolo[2,3-b]pyridin]-2'(1'H)-one
MK-8031-028957122-47-3在售3-amino-1'-((2-(trimethylsilyl)ethoxy)methyl)-5,7-dihydrospiro[cyclopenta[b]pyridine-6,3'-pyrrolo[2,3-b]pyridin]-2'(1'H)-one
MK-8031-029957122-44-0在售3-amino-5,7-dihydrospiro[cyclopenta[b]pyridine-6,3'-pyrrolo[2,3-b]pyridin]-2'(1'H)-one
MK-8031-0301059186-43-4在售(R)-3-amino-5,7-dihydrospiro[cyclopenta[b]pyridine-6,3'-pyrrolo[2,3-b]pyridin]-2'(1'H)-one
MK-8031-0311189570-15-7在售(R)-3-iodo-5,7-dihydrospiro[cyclopenta[b]pyridine-6,3'-pyrrolo[2,3-b]pyridin]-2'(1'H)-one
MK-8031-0321375541-24-4在售methyl (R)-2'-oxo-1',2',5,7-tetrahydrospiro[cyclopenta[b]pyridine-6,3'-pyrrolo[2,3-b]pyridine]-3-carboxylate
优化Route 4步骤 5 · 总收率 /
MK-8031-03389-00-9MK-8031-03498555-51-2MK-8031-0351356330-71-6MK-8031-0361318253-26-7MK-8031-0371375542-65-6API · 阿托吉泮
编号CAS 号中间体名称
MK-8031-03389-00-9在售pyridine-2,3-dicarboxylic acid
MK-8031-03498555-51-2在售dimethyl 5-bromopyridine-2,3-dicarboxylate
MK-8031-0351356330-71-6在售(5-bromopyridine-2,3-diyl)dimethanol hydrochloride
MK-8031-0361318253-26-7在售3-bromo-1'-((2-(trimethylsilyl)ethoxy)methyl)-5,7-dihydrospiro[cyclopenta[b]pyridine-6,3'-pyrrolo[2,3-b]pyridin]-2'(1'H)-one
MK-8031-0371375542-65-6在售methyl (S)-2'-oxo-1'-((2-(trimethylsilyl)ethoxy)methyl)-1',2',5,7-tetrahydrospiro[cyclopenta[b]pyridine-6,3'-pyrrolo[2,3-b]pyridine]-3-carboxylate
优化Route 5步骤 9 · 总收率 3.1 g
MK-8031-038137628-17-2MK-8031-0391227585-65-0MK-8031-0401455358-05-1MK-8031-0411455358-06-1MK-8031-042—MK-8031-0431455358-11-8MK-8031-0441455358-12-9MK-8031-045—MK-8031-0461455358-14-1MK-8031-0471455358-16-3MK-8031-048—MK-8031-04919614-12-1API · 阿托吉泮
编号CAS 号中间体名称
MK-8031-038137628-17-2在售2,3-dibromo-5-chloropyridine
MK-8031-0391227585-65-0在售(2-bromo-5-chloropyridin-3-yl)methanol
MK-8031-0401455358-05-1在售5-chloro-3-(((tetrahydro-2H-pyran-2-yl)oxy)methyl)picolinaldehyde
MK-8031-0411455358-06-1在售1-(tert-butyl)-1,3-dihydro-2H-pyrrolo[2,3-b]pyridin-2-one
MK-8031-042-(E)-1-(tert-butyl)-3-((5-chloro-3-(((tetrahydro-2H-pyran-2-yl)oxy)methyl)pyridin-2-yl)methylene)-1,3-dihydro-2H-pyrrolo[2,3-b]pyridin-2-one
MK-8031-0431455358-11-8在售1-(tert-butyl)-3-((5-chloro-3-(hydroxymethyl)pyridin-2-yl)methyl)-1,3-dihydro-2H-pyrrolo[2,3-b]pyridin-2-one
MK-8031-0441455358-12-9在售1-(tert-butyl)-3-((5-chloro-3-(chloromethyl)pyridin-2-yl)methyl)-1,3-dihydro-2H-pyrrolo[2,3-b]pyridin-2-one
MK-8031-045-(1S,2R,4S,5R)-1-(2-bromo-5-methoxybenzyl)-2-((S)-(1-(2-bromo-5-methoxybenzyl)-6-methylquinolin-1-ium-4-yl)(hydroxy)methyl)-5-vinylquinuclidin-1-ium
MK-8031-0461455358-14-1在售(S)-1'-(tert-butyl)-3-chloro-5,7-dihydrospiro[cyclopenta[b]pyridine-6,3'-pyrrolo[2,3-b]pyridin]-2'(1'H)-one
MK-8031-0471455358-16-3在售(S)-1'-(tert-butyl)-2'-oxo-1',2',5,7-tetrahydrospiro[cyclopenta[b]pyridine-6,3'-pyrrolo[2,3-b]pyridine]-3-carboxylic acid
MK-8031-048-(S)-(6-methylquinolin-4-yl)((1S,2R,4S,5R)-5-vinylquinuclidin-2-yl)methanol
MK-8031-04919614-12-1在售1-bromo-2-(bromomethyl)-4-methoxybenzene
优化Route 6步骤 5 · 总收率 3.75 g
MK-8031-050—MK-8031-051—MK-8031-052—MK-8031-0531455358-36-7MK-8031-054—API · 阿托吉泮
编号CAS 号中间体名称
MK-8031-050-2-bromo-5-chloro-3-(((triisopropylsilyl)oxy)methyl)pyridine
MK-8031-051-methyl 5-chloro-3-(((triisopropylsilyl)oxy)methyl)picolinate
MK-8031-052-5-chloro-2-(chloromethyl)-3-(((triisopropylsilyl)oxy)methyl)pyridine
MK-8031-0531455358-36-7在售methyl 1-(tert-butyl)-2-oxo-2,3-dihydro-1H-pyrrolo[2,3-b]pyridine-3-carboxylate
MK-8031-054-methyl 1-(tert-butyl)-3-((5-chloro-3-((triisopropylsilyl)oxy)pyridin-2-yl)methyl)-2-oxo-2,3-dihydro-1H-pyrrolo[2,3-b]pyridine-3-carboxylate

常见问题(FAQ)

阿托吉泮的适应症有哪些?

已批准的适应症包括:偏头痛。

阿托吉泮的专利什么时候到期?

阿托吉泮的专利到期年暂无公开口径,本页会在数据管道核实后更新。

阿托吉泮有几条合成路线?

本站收录 7 条合成路线,最短路线 3 步、总收率 5.40 g。每条路线的中间体均带登记编号与 CAS 号。

阿托吉泮的关键中间体在哪里可以采购?

阿托吉泮的多条路线中间体已挂接 CAS 档案,其中 43 个 CAS 已有优贝德(Unibest)供应网络在售报价,可在本页路线表中直接查看并询价。

如何获取阿托吉泮中间体的报价?

在本页选择目标中间体的 CAS 进入档案页,或在询价页直接提交需求;CAS 会自动带入供需撮合流程,由供应网络反馈报价。

数据来源:多源数据交叉核实(仅结构化字段) · 2026-09-27